ホーム › 頭頸部扁平上皮癌 › ミシガン州 › Ann Arbor
Ann Arbor、MIにおける頭頸部扁平上皮癌の臨床試験
Ann Arborとその周辺地域（約30マイル以内）の拠点で、頭頸部扁平上皮癌に関する12件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
被験者募集中第2/3相
- University of Michigan (Site # 161), Ann Arbor
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
被験者募集中第3相
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7マイル先
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15マイル先
- 他1件
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
被験者募集中第3相
- Trinity Health St Joseph Mercy Ann Arbor, Ann Arbor
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
被験者募集中第1/2相
- University of Michigan Rogel Cancer Center, Ann Arbor
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
被験者募集中第2相
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7マイル先
- 他5件
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
被験者募集中第2相
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7マイル先
- 他6件
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
被験者募集中第2/3相
- University of Michigan Rogel Cancer Center, Ann Arbor
Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial
被験者募集中第2相
- University of Michigan Comprehensive Cancer Center, Ann Arbor
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
被験者募集中第1相
- University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 252010, Ann Arbor
A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze)
被験者募集中第2相
- University of Michigan Rogel Cancer Center, Ann Arbor
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
被験者募集中第1/2相
- University of Michigan, Ann Arbor
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
被験者募集中第1/2相
- University of Michigan, Ann Arbor
他の都市における頭頸部扁平上皮癌の試験
- Houston, TX47件の研究
- Los Angeles, CA42件の研究
- Boston, MA40件の研究
- New York City, NY39件の研究
- Nashville, TN39件の研究
- St. Louis, MO28件の研究
- Arlington, VA26件の研究
- Philadelphia, PA26件の研究
- Chicago, IL26件の研究
- Atlanta, GA24件の研究
- San Antonio, TX22件の研究
- New Haven, CT22件の研究
Ann Arborにおける他の研究
- 乳がん27件の研究
- 前立腺がん27件の研究
- 非小細胞肺癌26件の研究
- がん（全種類）25件の研究
- 肺がん23件の研究
- 大腸癌23件の研究
- 心不全22件の研究
- 急性骨髄性白血病17件の研究
- 心血管疾患16件の研究
- 膵臓がん14件の研究
- 悪性黒色腫12件の研究
- 脳卒中12件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。